Alcoholic Intoxication
Welcome,         Profile    Billing    Logout  
 4 Companies   5 Products   5 Products   8 Mechanisms of Action   1 Trial   48 News 
  • ||||||||||  Trial completion:  BADS: Behavior and Driving Safety Study (clinicaltrials.gov) -  Jan 5, 2019   
    P=N/A,  N=864, Completed, 
    N=580 --> 222 | Trial completion date: Jun 2019 --> Oct 2018 | Not yet recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Oct 2018; The number of participants included and especially who connected to the application (less than 50% of the target) does not meet the objective set by the study. Active, not recruiting --> Completed
  • ||||||||||  Trial completion date, Trial primary completion date:  BADS: Behavior and Driving Safety Study (clinicaltrials.gov) -  Feb 13, 2018   
    P=N/A,  N=800, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jan 2018 --> Dec 2018 | Trial completion date: Jan 2018 --> Dec 2018
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Behavior and Driving Safety Study II (clinicaltrials.gov) -  Jul 11, 2017   
    P=N/A,  N=200, Completed, 
    Trial primary completion date: Jan 2018 --> Dec 2018 | Trial completion date: Jan 2018 --> Dec 2018 Active, not recruiting --> Completed | N=100 --> 200 | Trial primary completion date: Dec 2013 --> Dec 2015
  • ||||||||||  Trial primary completion date:  BADS: Behavior and Driving Safety Study (clinicaltrials.gov) -  Jun 27, 2017   
    P=N/A,  N=800, Active, not recruiting, 
    Active, not recruiting --> Completed | N=100 --> 200 | Trial primary completion date: Dec 2013 --> Dec 2015 Trial primary completion date: Dec 2013 --> Jan 2018
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (clinicaltrials.gov) -  Jun 15, 2017   
    P2,  N=18, Completed, 
    Trial primary completion date: Dec 2013 --> Jan 2018 Recruiting --> Completed | N=124 --> 18 | Trial primary completion date: Sep 2020 --> Jun 2017
  • ||||||||||  Trial completion:  Acute and Residual Effects of Caffeinated Beer (clinicaltrials.gov) -  Jul 24, 2016   
    P2,  N=144, Completed, 
    Recruiting --> Completed | N=124 --> 18 | Trial primary completion date: Sep 2020 --> Jun 2017 Recruiting --> Completed
  • ||||||||||  topiramate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) -  Feb 18, 2016   
    P2,  N=4, Terminated, 
    Recruiting --> Completed N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV.
  • ||||||||||  zonisamide / Generic mfg.
    Enrollment change, Trial termination:  Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) -  Jan 7, 2016   
    P2,  N=3, Terminated, 
    N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV. N=40 --> 3 | Recruiting --> Terminated; recruitment infeasible
  • ||||||||||  Trial completion:  Emergency Department (ED) Triage of Alcohol Abuse (clinicaltrials.gov) -  Dec 29, 2015   
    P=N/A,  N=775, Completed, 
    N=40 --> 3 | Recruiting --> Terminated; recruitment infeasible Recruiting --> Completed
  • ||||||||||  zonisamide / Generic mfg.
    Trial primary completion date:  Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) -  Jul 15, 2015   
    P2,  N=40, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Apr 2015 --> Apr 2016
  • ||||||||||  zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) -  Apr 7, 2015   
    P2,  N=85, Terminated, 
    Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014 N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project.
  • ||||||||||  quetiapine / Generic mfg.
    Trial completion, Trial primary completion date:  Seroquel for Frequent, Heavy Drinkers (clinicaltrials.gov) -  Sep 19, 2014   
    P2,  N=156, Completed, 
    N=160 --> 85 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Aug 2013; Recruitment goals could not be met before ending of funding for this project. Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jan 2013
  • ||||||||||  Trial completion, Phase classification:  Motivational Interviews for Incarcerated Teens - 1 (clinicaltrials.gov) -  Aug 19, 2014   
    P=N/A,  N=200, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jan 2013 Recruiting --> Completed | Phase classification: P2 --> PN/A
  • ||||||||||  Chantix (varenicline) / Pfizer
    Trial completion:  Varenicline to Reduce Alcohol Consumption in Heavy Drinkers (clinicaltrials.gov) -  Jul 12, 2014   
    P1/2,  N=50, Completed, 
    Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed
  • ||||||||||  zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
    Enrollment closed:  Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) -  Nov 13, 2013   
    P2,  N=160, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Chantix (varenicline) / Pfizer
    Enrollment change:  Varenicline to Reduce Alcohol Consumption in Heavy Drinkers (clinicaltrials.gov) -  Aug 28, 2013   
    P1/2,  N=50, Active, not recruiting, 
    Recruiting --> Active, not recruiting N=180 --> 50
  • ||||||||||  Chantix (varenicline) / Pfizer
    Enrollment closed:  Varenicline to Reduce Alcohol Consumption in Heavy Drinkers (clinicaltrials.gov) -  Aug 28, 2013   
    P1/2,  N=50, Active, not recruiting, 
    N=180 --> 50 Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment closed:  Behavior and Driving Safety Study II (clinicaltrials.gov) -  Oct 26, 2012   
    P=N/A,  N=100, Active, not recruiting, 
    Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Enrollment closed:  BADS: Behavior and Driving Safety Study (clinicaltrials.gov) -  Oct 26, 2012   
    P=N/A,  N=800, Active, not recruiting, 
    Enrolling by invitation --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Chantix (varenicline) / Pfizer
    Trial completion:  NCIG 003: Varenicline for Alcohol Dependence (clinicaltrials.gov) -  Oct 15, 2012   
    P2,  N=200, Completed, 
    Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  quetiapine / Generic mfg.
    Enrollment closed:  Seroquel for Frequent, Heavy Drinkers (clinicaltrials.gov) -  Jul 4, 2012   
    P2,  N=180, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  zonisamide / Generic mfg.
    Enrollment open:  Zonisamide for Heavy Drinkers With Bipolar Disorder (clinicaltrials.gov) -  May 8, 2012   
    P2,  N=40, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting